Specific phobia of vomiting, often called emetophobia, can shape a life in ways that are difficult for others to see. Avoiding particular foods. Staying away from restaurants or travel. Keeping clear of anyone who might be unwell, or reconsidering pregnancy altogether. The fear can quietly narrow almost every decision a person makes.
For all its disruptiveness, this phobia has proved difficult to study and to treat. Only one randomised controlled trial has examined treatment for it specifically. That gap is part of what makes newer research worth attention.
A recent single case study tested a different approach: time intensive cognitive behavioural therapy, delivered in a more concentrated format than standard weekly sessions, combined with imagery rescripting. Imagery rescripting helps people work through distressing mental images and memories, and it has already shown promise across a range of anxiety disorders. Other specific phobias have responded well to intensive formats, which formed part of the reasoning for testing the approach here.
The study set out to evaluate whether that combination could reduce symptoms, using a design that tracks one person's progress closely through treatment rather than comparing large groups.
If a fear of vomiting has been shaping your choices for a long time, a psychologist who works with anxiety and phobias can talk through which treatment options might suit your situation.
What "specific phobia of vomiting" actually is
Emetophobia's clinical name is Specific Phobia of Vomiting (SPOV). In diagnostic terms, a specific phobia is an intense, persistent fear of a particular object or situation that is out of proportion to the actual danger, and that leads to avoidance or significant distress. SPOV fits this pattern, but it's an unusually under-researched one — the study we're looking at here notes that, at the time it was written, only one randomised controlled trial (RCT) had ever been published on treating SPOV. An RCT is a study design where participants are randomly assigned to a treatment or comparison group, which helps researchers work out whether a treatment itself is causing improvement, rather than something else (like time passing). Having just one such trial means the evidence base for SPOV is still being built.
What this particular study did
Because large trials are resource-intensive and SPOV research is still young, this study used a different method: a single case experimental design (SCED). Instead of comparing groups of people, a SCED studies one person (or a small number of people) very closely, taking repeated measurements of their symptoms before, during, and after treatment. This lets researchers see whether change in symptoms lines up with the introduction of treatment — a way of building evidence about what might work before it's tested in a full trial.
The treatment being tested combined two ingredients. The first is time-intensive Cognitive Behavioural Therapy (CBT) — the same evidence-based therapy used for many anxiety disorders, but compressed into a shorter time frame rather than spread across weekly sessions over months. The second is imagery rescripting (ImRs), a technique in which someone brings to mind a distressing mental image (for example, a memory or feared scenario connected to vomiting) and works with a therapist to consciously alter it — changing the ending, adding new information, or shifting the emotional meaning — with the aim of reducing the fear response attached to it. ImRs has an established track record as a helpful component in treating various anxiety disorders more broadly.
Why this combination was worth testing
The reasoning behind the study is grounded in existing research: intensive treatment formats have been shown to work well for specific phobias in general, and imagery rescripting has a track record in anxiety treatment more broadly. Putting these two evidence-based ingredients together for SPOV specifically was the logical next step — and testing it in a detailed, single-case format was a sensible way to start given how little SPOV-specific research exists.
Why it matters, and its limits
A single case design can't tell us how a treatment performs across many different people the way an RCT can, and it can't produce the kind of statistics that let researchers generalise confidently. What it can do is provide detailed, carefully measured evidence about a promising treatment approach in a field that badly needs more research. Studies like this help build the case for larger trials down the line, and add real, close-up detail to our understanding of how SPOV might respond to intensive CBT and imagery rescripting.
If reading this resonates with your own experience, know that support exists and that reaching out to a psychologist who understands phobias is a reasonable, worthwhile step to take.